Inhibition of effector function but not T cell activation and increase in FoxP3 expression in T cells differentiated in the presence of PP14

PLoS ONE

Volumn 5, Issue 9, 2010, Pages 1-10

  Ochanuna, Zohar ^a   Geiger Maor, Anat ^a   Dembinsky Vaknin, Adi ^a   Karussis, Dimitrios ^a   Tykocinski, Mark L ^b   Rachmilewitz, Jacob ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 5; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PLACENTA PROTEIN 14; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; GLYCOPROTEIN; PAEP PROTEIN, HUMAN; PLACENTA PROTEIN;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; EMBRYO; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; GENE EXPRESSION; GENETICS; HELPER CELL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MIDDLE AGED; T LYMPHOCYTE;

ADULT; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; GLYCOPROTEINS; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PREGNANCY PROTEINS; T-LYMPHOCYTES; T-LYMPHOCYTES, HELPER-INDUCER; YOUNG ADULT;

EID: 77958540006     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012868     Document Type: Article

References (57)

1. Kontopidis G, Holt C, Sawyer L (2004) Invited review: beta-lactoglobulin: binding properties, structure, and function. J Dairy Sci 87: 785-796.
2. Lapid K, Sharon N (2006) Meet the multifunctional and sexy glycoforms of glycodelin. Glycobiology 16: 39R-45R.
3. Bell SC, Drife JO (1989) Secretory proteins of the endometrium-potential markers for endometrial dysfunction. Baillieres Clin Obstet Gynaecol 3: 271-291.
4. Seppala M, Taylor RN, Koistinen H, Koistinen R, Milgrom E (2002) Glycodelin: a major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation. Endocr Rev 23: 401-430.
5. Koistinen H, Koistinen R, Dell A, Morris HR, Easton RL, et al. (1996) Glycodelin from seminal plasma is a differentially glycosylated form of contraceptive glycodelin-A. Mol Hum Reprod 2: 759-765.
6. Song M, Ramaswamy S, Ramachandran S, Flowers LC, Horowitz IR, et al. (2001) Angiogenic role for glycodelin in tumorigenesis. Proc Natl Acad Sci U S A 98: 9265-9270.
7. Pockley AG, Bolton AE (1989) Placental protein 14 (PP14) inhibits the synthesis of interleukin-2 and the release of soluble interleukin-2 receptors from phytohaemagglutinin- stimulated lymphocytes. Clin Exp Immunol 77: 252-256.
8. Pockley AG, Bolton AE (1989) The effect of human placental protein 14 (PP14) on the production of interleukin-1 fom mitogenically stimulated mononuclear cell cultures. Biology 69: 277-281.
9. Mukhopadhyay D, SundarRaj S, Alok A, Karande AA (2004) Glycodelin A, not glycodelin S, is apoptotically active. Relevance of sialic acid modification. J Biol Chem 279: 8577-8584.
10. Karande AA, Mukhopadhyay D, Jayachandran R, Sundarraj S, Alok A (2005) Mechanism of the immunomodulatory activity of glycodelin. Indian J Physiol Pharmacol 49: 271-283.
11. Jayachandran R, Radcliffe CM, Royle L, Harvey DJ, Dwek RA, et al. (2006) Oligosaccharides modulate the apoptotic activity of glycodelin. Glycobiology 16: 1052-1063.
12. Van den Nieuwenhof IM, Koistinen H, Easton RL, Koistinen R, Kamarainen M, et al. (2000) Recombinant glycodelin carrying the same type of glycan structures as contraceptive glycodelin-A can be produced in human kidney 293 cells but not in chinese hamster ovary cells. Eur J Biochem 267: 4753-4762.
13. Rachmilewitz J, Riely GJ, Huang JH, Chen A, Tykocinski ML (2001) A rheostatic mechanism for T-cell inhibition based on elevation of activation thresholds. Blood 98: 3727-3732.
14. Rachmilewitz J, Borovsky Z, Riely GJ, Miller R, Tykocinski ML (2003) Negative regulation of T cell activation by placental protein 14 is mediated by the tyrosine phosphatase receptor CD45. J Biol Chem 278: 14059-14065.
15. Nguyen JT, Evans DP, Galvan M, Pace KE, Leitenberg D, et al. (2001) CD45 modulates galectin-1-induced T cell death: regulation by expression of core 2 O-glycans. J Immunol 167: 5697-5707.
16. Ish-Shalom E, Gargir A, Andre S, Borovsky Z, Ochanuna Z, et al. (2006) alpha 2, 6-Sialylation promotes binding of placental protein 14 via its Ca2+-dependent lectin activity: insights into differential effects on CD45RO and CD45RA T cells. Glycobiology 16: 173-183.
17. Mishan-Eisenberg G, Borovsky Z, Weber MC, Gazit R, Tykocinski ML, et al. (2004) Differential regulation of Th1/Th2 cytokine responses by placental protein 14. J Immunol 173: 5524-5530.
18. Cho TH, Chang SH, Jan YS (2000) Dose-dependent selective priming of Th1 and Th2 immune responses is achieved only by an antigen with an affinity over a certain threshold level. Mol Cells 10: 695-704.
19. Tejada-Simon MV, Hong J, Rivera VM, Zhang JZ (2001) Reactivity pattern and cytokine profile of T cells primed by myelin peptides in multiple sclerosis and healthy individuals. Eur J Immunol 31: 907-917.
20. Marie JC, Liggitt D, Rudensky AY (2006) Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. Immunity 25: 441-454.
21. Walker MR, Kasprowicz DJ, Gersuk VH, Benard A, Van Landeghen M, et al. (2003) Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J Clin Invest 112: 1437-1443.
22. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S (2002) Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 3: 135-142.
23. McHugh RS, Whitters MJ, Piccirillo CA, Young DA, Shevach EM, et al. (2002) CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16: 311-323.
24. Coombes JL, Siddiqui KR, Arancibia-Carcamo CV, Hall J, Sun CM, et al. (2007) A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 204: 1757-1764.
25. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, et al. (2007) Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317: 256-260.
26. Xiao S, Jin H, Korn T, Liu SM, Oukka M, et al. (2008) Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J Immunol 181: 2277-2284.
27. Newcomer ME (1995) Retinoid binding proteins: structural determinants important for function. Faseb J 9: 229-239.
28. Sauer S, Bruno L, Hertweck A, Finlay D, Leleu M, et al. (2008) T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc Natl Acad Sci U S A 105: 7797-7802.
29. Rachmilewitz J, Borovsky Z, Mishan-Eisenberg G, Yaniv E, Riely GJ, et al. (2002) Focal localization of placental protein 14 toward sites of TCR engagement. J Immunol 168: 2745-2750.
30. Hamalainen H, Zhou H, Chou W, Hashizume H, Heller R, et al. (2001) Distinct gene expression profiles of human type 1 and type 2 T helper cells. Genome Biol 2: RESEARCH0022.
31. Murphy KM, Reiner SL (2002) The lineage decisions of helper T cells. Nat Rev Immunol 2: 933-944.
32. Agnello D, Lankford CS, Bream J, Morinobu A, Gadina M, et al. (2003) Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. J Clin Immunol 23: 147-161.
33. Swain SL, Weinberg AD, English M (1990) CD4+ T cell subsets. Lymphokine secretion of memory cells and of effector cells that develop from precursors in vitro. J Immunol 144: 1788-1799.
34. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, et al. (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6: 1123-1132.
35. Park H, Li Z, Yang XO, Chang SH, Nurieva R, et al. (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6: 1133-1141.
36. Rachmilewitz J, Lanzavecchia A (2002) A temporal and spatial summation model for T-cell activation: signal integration and antigen decoding. Trends Immunol 23: 592-595.
37. Zhang JW, Schreurs M, Medaer R, Raus JC (1992) Regulation of myelin basic protein-specific helper T cells in multiple sclerosis: generation of suppressor T cell lines. Cell Immunol 139: 118-130.
38. Achiron A, Lavie G, Kishner I, Stern Y, Sarova-Pinhas I, et al. (2004) T cell vaccination in multiple sclerosis relapsing-remitting nonresponders patients. Clin Immunol 113: 155-160.
39. Ouyang W, Kolls JK, Zheng Y (2008) The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28: 454-467.
40. Dong C, Yang DD, Tournier C, Whitmarsh AJ, Xu J, et al. (2000) JNK is required for effector T-cell function but not for T-cell activation. Nature 405: 91-94.
41. McClain MA, Gatson NN, Powell ND, Papenfuss TL, Gienapp IE, et al. (2007) Pregnancy suppresses experimental autoimmune encephalomyelitis through immunoregulatory cytokine production. J Immunol 179: 8146-8152.
42. Amsalem H, Gaiger A, Mizrahi S, Yagel S, Rachmilewitz J (2008) Characterization of a lymphocyte subset displaying a unique regulatory activity in human decidua. Int Immunol 20: 1147-1154.
43. Julkunen M, et al. (1986) Placental protein 14 and progestagen-dependent endometrial protein are immunologically indistinguishable. Human Reprod 1: 7-8.
44. Seppala M, Suikkari AM, Koistinen R, Riittinen L, Julkunen M (1990) Endometrial protein secretion with respect to endometrial and ovarian function. Eur J Obstet Gynecol Reprod Biol 36: 250-257.
45. Buyon JP, Nelson JL, Lockshin MD (1996) The effects of pregnancy on autoimmune diseases. Clin Immunol Immunopathol 78: 99-104.
46. Culouscou JM, Remacle-Bonnet MM, Pommier G, Rance RJ, Depieds RC (1986) Immunosuppressive properties of human placenta: study of supernatants from short-term syncytiotrophoblast cultures. J Reprod Immunol 9: 33-47.
47. Mincheva-Nilsson L, Hammarstrom S, Hammarstrom ML (1992) Human decidual leukocytes from early pregnancy contain high numbers of gamma delta+ cells and show selective down-regulation of alloreactivity. J Immunol 149: 2203-2211.
48. Weetman AP (1999) The immunology of pregnancy. Thyroid 9: 643-646.
49. Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
50. Gambineri E, Torgerson TR, Ochs HD (2003) Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 15: 430-435.
51. Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, et al. (1997) TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. Embo J 16: 5353-5362.
52. Wohlfert EA, Gorelik L, Mittler R, Flavell RA, Clark RB (2006) Cutting edge: deficiency in the E3 ubiquitin ligase Cbl-b results in a multifunctional defect in T cell TGF-beta sensitivity in vitro and in vivo. J Immunol 176: 1316-1320.
53. Hay N, Sonenberg N (2004) Upstream and downstream of mTOR. Genes Dev 18: 1926-1945.
54. Takano A, Usui I, Haruta T, Kawahara J, Uno T, et al. (2001) Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin. Mol Cell Biol 21: 5050-5062.
55. Tremblay F, Marette A (2001) Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells. J Biol Chem 276: 38052-38060.
56. Delgoffe GM, Kole TP, Zheng Y, Zarek PE, Matthews KL, et al. (2009) The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 30: 832-844.
57. Borovsky Z, Mishan-Eisenberg G, Yaniv E, Rachmilewitz J (2002) Serial triggering of T cell receptors results in incremental accumulation of signaling intermediates. J Biol Chem 277: 21529-21536.